dimarts, 21 d’abril del 2015

Medtronic launches stent graft feasibility study

Medtronic says it launched a feasibility trial of its Valiant Mona LSA branch stent graft for treating aortic aneurysms affecting the left subclavian artery.

Medtronic launches stent graft feasibility study

Medtronic (NYSE:MDT) said today that it launched a new feasibility study of its Valiant Mona LSA stent graft in treating aortic aneurysms affecting the left subclavian artery.

read more



from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1zGR3v0

Cap comentari:

Publica un comentari a l'entrada